Skip to main content
  • David Weber, MD, MPH

    Weber Discusses Possibilities Of Second COVID Wave

    David Weber, MD, MPH, medical director of hospital epidemiology (infection prevention), talked with ABC 11 News about new concerns for a second wave. The story reports that Weber “believes it’s not a question of when we’ll have more peaks but how big they are.” Weber, a professor of medicine in the division of infectious diseases, says “we’re not going to know for two or maybe fo … Continued

  • QA-David-Wohl

    Q&A With David Wohl on COVID-19 and HIV

    David Wohl, MD, professor of medicine in the division of infectious diseases, offered insight into the current pandemic based on what he witnessed during the Ebola epidemic in an interview with Test Positive Aware Network (TPAN)’s Positively Aware. “Right now, what holds for people living without HIV holds for people living with HIV,” Wohl said in the interview.  “This includes k … Continued

  • Adaora A. Adimora, MD, MPH

    Adimora Addresses Concern For the Effects of COVID-19 Among People Living With HIV

    Ada Adimora, MD, MPH, the Sarah Graham Kenan Distinguished Professor of Medicine in the division of infectious diseases, expressed concern in an interview with Healio Infectious Disease News, about the lack of studies regarding the specific impact of effect of COVID-19 in people living with HIV (PLWH). “People with well-controlled HIV have an excellent prognosis from an HIV stand … Continued

  • Schranz Asher, MD

    Schranz Receives Grant from NIH National Institute on Drug Abuse

    Asher Schranz, MD, MPH, assistant professor of medicine in the division of infectious diseases, has received a grant from the NIH National Institute on Drug Abuse (NIDA) for the project “Drug-use associated infective endocarditis: Post-hospitalization outcomes and patient treatment preferences.” Schranz’s research is broadly focused on the intersection of infectious diseases and … Continued

  • hiv-gen-med-clinic

    Novel Primary Care Model Promotes Lifelong Comprehensive Care for People Living with HIV

    Shana Ratner, MD, associate professor in the division of general medicine, and section chief for education and clinical practice, announces a novel collaboration with the division of infectious diseases that includes a multidisciplinary primary care clinic to serve people living with HIV. The new model lays the groundwork for multidisciplinary care in advance of the move to Easto … Continued

  • MikeCohenNAMheadshotsJCL201.jpg

    Cohen Comments On Fauci and Birx As National COVID-19 Advisors

    Myron Cohen, MD, professor of medicine in the division of infectious diseases, has known NIH Director Anthony S. Fauci, MD, and Deborah Birx, MD, the White House Coronavirus Response Coordinator, since the 1980s, he told the Washington Post in a recent interview. Speaking on their partnership as scientists and public health officials, he emphasized that “the pair are too driven b … Continued

  • David Wohl, MD

    Wohl Discusses Testing Shortages With New York Post

    David Wohl, MD, professor of medicine in the division of infectious diseases, says the signs were clear in early February and that was the time to ramp up, in the New York Post article “Rich and famous get COVID-19 test but average people can’t.”  Wohl expresses his concerns about “a serious lack of preparation and coordination” in overall response. Find the article here.

  • David Weber, MD, MPH, is a professor of medicine and pediatrics in the UNC School of Medicine and a professor of epidemiology in the UNC Gillings School of Global Public Health

    Weber Answers Coronavirus Questions on People’s Pharmacy

    David Weber, MD, MPH, professor of medicine in the division of infectious diseases, answered questions about COVID-19 on The People’s Pharmacy with Joe and Terry Graedon. He explained a cytokine storm and the immune reaction to the virus. He also discussed drugs being considered for treatment. The March 26 podcast can be accessed here.

  • david-margolis

    ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership

    This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the UNC Cure Center. “Without the Qura partnership we would not have been able to get this far, this fast,” said Da … Continued

  • Clare Mock, MD

    IHQI Improvement Scholars Announced, Five in Medicine

    The Institute for Healthcare Quality Improvement (IHQI) has announced projects that will be supported through IHQI’s Improvement Scholars Program. Half of these scholars are members of the UNC Department of Medicine, and they include the following.   Mildred Kwan, MD PhD, with lead Renae Boerneke, PharmD, BCPS, CPP — Reducing the Healthcare Utilization of Broad Spectrum Ant … Continued